Top Biotech Stocks to Watch
Are you familiar with the term Biotech Stocks? Biotech Stocks are stocks offered by biotech companies that develop drugs, therapies, treatments, and vaccines for a variety of health issues.
These stocks gained popularity in 2020 after the need for vaccine development. As a result, Biotech stocks provide opportunities for investors since they highly present a long-term return potential. However, these products have to obtain approval from the U.S. Food and Drug Administration (FDA) after undergoing rigorous, expensive and time-consuming trials.
This means investors are left in the speculation of whether a drug under development will pay off. Here are the top biotech stocks to watch which feature solid pipelines and even have winning drugs on the market.
1. Enzolytics Inc. (OTCPK: ENZC)
Founded in 2004 in Plano, Texas, United States. Enzolytics, Inc .is a biotechnology company, which focuses on the development and commercialization of drugs for the treatment of infectious diseases. Some of the company’s product objectives include Accelerated FDA approval, cure HIV and other diseases at a large scale, and mass production strategies through strategic partnership within the Biotech industry. The company has witnessed progress in finalizing clinical trials for its potential HIV therapy.
2. Novavax Inc. (NASDAQ: AXSM)
Founded in 1987 in Gaithersburg, Maryland, U.S. Novavax, Inc. is an American biotechnology company that engages in the development of vaccines for infectious diseases. Novavax recent vaccine candidate NVX-CoV2373 ranks as the safest and most effective vaccine when compared to Moderna, Pfzier and J&J.
As a result, Novavax received a $1.6 billion agreement with the U.S government to fund the final stage development and production of its COVID-19 vaccine. In addition, Novavax has also received supply deals of the vaccine with Canada, India, Australia and the U.K.
3. Exelixis (NASDAQ: NVAX)
Founded in 1994 and based in Alameda, California, U.S, Exelixis, Inc. is genomics-based drug development company. This company is well known for the development and production of Cometriq, a treatment for medullary thyroid cancer which is currently its biggest winner. In addition, this biotech company boasts more than three drugs that are already on the market.
4. Lixte Biotechnology Holdings, Inc (NASDAQ: LIXT)
Founded in 2005, and based in the United States, Lixte Biotechnology Holdings, Inc. is a pharmaceutical company committed to discovering drugs for the effective treatment of cancer. This biotechnology firm uses biomarker technology to find targets responsible for serious diseases.
5. Regeneron Pharmaceuticals (NASDAQ: REGN)
This pharmaceutical company is responsible for the development of Eylea, an eye disease drug it manufactures in partnership with Bayer (OTC: BAYRY). In addition, the company also develops drugs for cancer, autoimmune, and infectious diseases.
The company also garnered a win for U.S Emergency Use Authorization (EUA) for treating COVID-19 with REGEN-COV; an antibody. The antibody features a significant reduction of the risk of symptomatic infection by the coronavirus. Therefore, Regeneron is expected to witness a potential increase in demand for this therapy.
6. Arvinas, Inc. (NASDAQ: ARVN)
Arvinas, Inc. is a biopharmaceutical company that develops protein degradation therapeutics for cancer and other diseases. Recently, the company partnered with Pfizer towards developing a drug meant to treat breast cancer. In addition, Arvinas witnessed a 30 % rise in its stock due to an equity investment made by Pfizer in the company.
